The efficient synthesis of mono- and dinuclear Os(IV) bipyridyl complexes is reported. These compounds show a two-step oxidation process leading to notable structural changes, which are reflected in their emission properties. During the second oxidation process a tetracation with a hydride-dihydrogen structure (instead of a trihydride) is formed. This results in a significant bathochromic shift of the emission band, accompanied by a moderate increase in intensity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c2dt32548a | DOI Listing |
Acta Crystallogr E Crystallogr Commun
October 2024
Department of Chemistry, KU Leuven, Biomolecular Architecture, Celestijnenlaan 200F, Leuven (Heverlee), B-3001, Belgium.
Two new zinc(II) complexes, tri-ethyl-ammonium di-chlorido-[2-(4-nitro-phen-yl)-4-phenyl-quinolin-8-olato]zinc(II), (CHN){Zn(CHNO)Cl] (), and bis-(tri-ethyl-ammonium) {2,2'-[1,4-phenyl-enebis(nitrilo-methyl-idyne)]diphenolato}bis-[di-chlorido-zinc(II)], (CHN)[Zn(CHNO)Cl] (), were synthesized and their structures were determined using ESI-MS spectrometry, H NMR spectroscopy, and single-crystal X-ray diffraction. The results showed that the ligands 2-(4-nitro-phen-yl)-4-phenyl-quinolin-8-ol () and ,'-bis-(2-hy-droxy-benzyl-idene)benzene-1,4-di-amine () were deprotonated by tri-ethyl-amine, forming the counter-ion EtNH, which inter-acts an N-H⋯O hydrogen bond with the ligand. The Zn atoms have a distorted trigonal-pyramidal () and distorted tetra-hedral () geometries with a coord-ination number of four, coordinating with the ligands N and O atoms.
View Article and Find Full Text PDFDalton Trans
November 2024
Department of Chemistry, Banaras Hindu University, Varanasi 221005, India.
Cancer is a prominent global cause of mortality. Palladium complexes have the potential to serve as effective anticancer and pharmacological agents, offering a viable alternative to platinum medications. This work focused on the development of a new thiolato-bridged dinuclear [Pd(M3MPyThU)Cl]2 and mononuclear palladium [Pd(M3MPyThU)2] complexes containing 1-methyl-3-(3-methylpyridin-2-yl) thiourea (HM3MPyThU) ligand.
View Article and Find Full Text PDFInt J Biol Macromol
December 2024
Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals, Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Hubei University, Wuhan 430062, PR China. Electronic address:
Transition metal complexes has been explored in the treatment of tumors in photodynamic theray (PDT) or photothermal therapy (PTT) and Osmium complex attracts attentration due to its lower toxicity and longer absorption wavelength. However, there was no report about binuclear Os complex for combined therapy of PDT and PTT which could have a synergistic effect and improve the effectiveness. Herein, we synthesis of mono/dinuclear Os complexes (OsY1, OsY2) with dual PDT/PTT capabilities under a single near-infrared (NIR) excitation wavelength.
View Article and Find Full Text PDFJ Inorg Biochem
January 2025
Department of Chemistry, University of South Florida, Tampa, FL 33620-5250, USA; Institute of Drug Discovery Technology, Ningbo University, Ningbo, Zhejiang 315211, PR China. Electronic address:
Dalton Trans
November 2024
School of Chemistry, University of Leicester, University Road, Leicester, LE1 7RH, UK.
A diprotic bis(β-thioketoimine) ligand precursor featuring a flexible 4,4'-methylbis(aniline) linker, H2, was synthesised treatment of the corresponding bis(β-ketoimine) with Lawesson's reagent. Lithiation of H2 and coordination with one equivalent of d-block metal(II) chlorides MCl(THF) (M = Fe, Co and Zn) yielded a corresponding series of homoleptic dinuclear complexes, [M(μ-2)]. X-ray diffraction analysis reveals a tetrahedral geometry for the two metals and a double-stranded helicate structure arising from inter-strand face-face π-stacking.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!